eFFECTOR Therapeutics, Inc. EFTR

Full chart Compare
Set alert

Price alert · EFTR

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0002 Day range 0.0002
0.0002 52-week range 0.01
YTD
0.00%
1 year
0.00%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 10.00
Ratings (-1m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • 1 month ago 2
  • 2 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

EFTR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-2.02-2.02 – -2.02-4.25+52.5%00.0%1
Next quarter-1.95-1.95 – -1.95-3.25+40.0%00.0%1
Current year-6.17-6.17 – -6.17-16.37+62.3%00.0%1
Next year-2.25-2.25 – -2.25-6.17+63.5%00.0%1

Upgrades and downgrades

The latest rating changes

EFTR analyst upgrades and downgrades
DateFirmActionFromTo
Aug 23, 2023HC Wainwright & Co.Initiated—Buy
May 25, 2023StifelUpgradeHoldBuy
May 9, 2023Credit SuisseMaintained—Outperform
Mar 8, 2023Credit SuisseMaintained—Outperform
Jan 8, 2023JMP SecuritiesMaintained—Market Outperform
Jan 5, 2023Credit SuisseMaintained—Outperform
Nov 16, 2022JMP SecuritiesMaintained—Market Outperform
Aug 10, 2022JMP SecuritiesMaintained—Market Outperform
Mar 16, 2022Credit SuisseMaintained—Outperform
Jan 24, 2022Credit SuisseMaintained—Outperform
Jan 24, 2022StifelDowngradeBuyHold
Jan 24, 2022JMP SecuritiesMaintained—Market Outperform
Nov 8, 2021StifelUpgradeHoldBuy
Oct 11, 2021Credit SuisseInitiated—Outperform
Oct 3, 2021MizuhoInitiated—Buy
Sep 20, 2021JMP SecuritiesInitiated—Market Outperform
Sep 19, 2021StifelInitiated—Hold
Sep 12, 2021Cantor FitzgeraldInitiated—Overweight